Ravgen, Inc.
Patent owner in reexamination·3 ex parte reexams
Ravgen, Inc.'s patents have been the subject of 3 USPTO ex parte reexaminations, with 1 currently open. Its patents are most often challenged by Natera, Inc. and Foundation Medicine, Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top requesters
Outcome track record
How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Claim-survival rate
Defense metrics
Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.
- Survival rate of closed proceedings
- Average pendency in months
Challengers & examiners
Which requesters most often challenge this owner's patents, and which examiners decide them.
- Top requesters
- Most frequent examiners
Recent reexaminations (3)
| Control # | Filed | Patent | Title | Requester | Status |
|---|---|---|---|---|---|
| 90/014,869 | Sep 24, 2021 | 7,727,720 | Methods for Detection of Genetic Disorders | Foundation Medicine, Inc. | Closed |
| 90/014,792 | Jul 2, 2021 | 7,332,277 | METHODS FOR DETECTION OF GENETIC DISORDERS | Natera, Inc. | Open |
| 90/014,703 | Mar 19, 2021 | 7,727,720 | Methods for Detection of Genetic Disorders | Natera, Inc. | Closed |
See the full reexam picture for Ravgen, Inc.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.